An in-depth look to OLIX PHARMACEUTICALS, INC. operating, investing, and financing activities

226950 free cash flow for Q3 24 is -12.83 B KRW. For 2023, 226950 free cash flow was -29.88 B KRW and operating cash flow was -21.17 B KRW.